UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Vaccine protection against Zika virus from Brazil

Nature (London), 2016-08, Vol.536 (7617), p.474-478

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib)

Vaccine, 2017-06, Vol.35 (30), p.3764-3772

2017

Link zum Volltext

Verfügbarkeit prüfen

Recent advancements in combination subunit vaccine development

Human vaccines & immunotherapeutics, 2017-01, Vol.13 (1), p.180-185

2017

Link zum Volltext

Verfügbarkeit prüfen

Advances in gene-based vaccine platforms to address the COVID-19 pandemic

Advanced drug delivery reviews, 2021-03, Vol.170, p.113-141

2021

Link zum Volltext

Verfügbarkeit prüfen

Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses

Journal of Virology, 2011-10, Vol.85 (20), p.10605-10616

2011

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

The Lancet (British edition), 2022-01, Vol.399 (10319), p.36-49

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and Safety of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T, bOPV, and IPV Vaccines Administered at 2, 4, 6 Months of Age Concomitantly With Rotavirus and Pneumococcal Conjugate Vaccines in Healthy Infants in Thailand

The Pediatric infectious disease journal, 2023-08, Vol.42 (8), p.711

2023

Link zum Volltext

Verfügbarkeit prüfen

Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge

The Journal of infectious diseases, 2019-11, Vol.220 (9), p.1521-1528

2019

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 Vaccine: A comprehensive status report

Virus research, 2020-10, Vol.288, p.198114-198114, Article 198114

2020

Link zum Volltext

Verfügbarkeit prüfen

Recent progress in mucosal vaccine development: potential and limitations

Nature reviews. Immunology, 2012-08, Vol.12 (8), p.592

Lycke, Nils

2012

Link zum Volltext

Verfügbarkeit prüfen

Foot-and-mouth disease vaccines: progress and problems

Expert review of vaccines, 2016-06, Vol.15 (6), p.783-789

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunological considerations for COVID-19 vaccine strategies

Nature reviews. Immunology, 2020-10, Vol.20 (10), p.615

2020

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 vaccines for cancer patients: a call to action

European journal of cancer (1990), 2021-05, Vol.148, p.316-327

2021

Link zum Volltext

Verfügbarkeit prüfen

Causal relationship between immunological responses and adverse reactions following vaccination

Vaccine, 2019-01, Vol.37 (2), p.366-371

Nakayama, Tetsuo

2019

Link zum Volltext

Verfügbarkeit prüfen

Blick in internationale Zeitschriften

Zeitschrift für Psychosomatische Medizin und Psychotherapie, 2021-12, Vol.67 (4), p.486-488

Doering, Stephan

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study

The Lancet infectious diseases, 2021-04, Vol.21 (4), p.546-558

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study

Vaccine, 2018-06, Vol.36 (28), p.4102-4111

2018

Link zum Volltext

Verfügbarkeit prüfen

An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix ™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children

Vaccine, 2011-06, Vol.29 (25), p.4264-4273

2011

Link zum Volltext

Verfügbarkeit prüfen

Virus-like particle-based human vaccines: quality assessment based on structural and functional properties

Trends in biotechnology (Regular ed.), 2013-11, Vol.31 (11), p.654-663

2013

Link zum Volltext

Verfügbarkeit prüfen

Plans to expand African vaccine production face steep hurdles

Science (American Association for the Advancement of Science), 2024-04, Vol.384 (6693), p.254-255

Cohen, Jon

2024

Link zum Volltext

Verfügbarkeit prüfen

A Review of the Progress and Challenges of Developing a Vaccine for COVID-19

Frontiers in immunology, 2020-10, Vol.11, p.585354

2020

Link zum Volltext

Verfügbarkeit prüfen

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Nature (London), 2021-04, Vol.592 (7853), p.283-289

2021

Link zum Volltext

Verfügbarkeit prüfen

Turning vaccine design on its head

Nature structural & molecular biology, 2024-02, Vol.31 (2), p.215

Ciazynska, Katarzyna

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 558.833

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(348.249)
Mit Volltextzugriff
(361.633)

Publikationsform

9 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(523.834)
Japanisch
(28.786)
Französisch
(9.651)
Russisch
(6.613)
Deutsch
(5.925)
Spanisch
(4.445)
Portugiesisch
(3.141)
Chinesisch
(2.726)
Polnisch
(1.499)
Italienisch
(1.447)
Niederländisch
(768)
Schwedisch
(649)
Urdu
(630)
Tschechisch
(526)
Norwegisch
(472)
Dänisch
(326)
Ungarisch
(292)
Rumänisch
(263)
Bulgarisch
(245)
Koreanisch
(237)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(282.082)
Vaccines
(266.603)
Life Sciences & Biomedicine
(259.171)
Humans
(220.528)
Animals
(115.130)
Immunization
(97.256)
Vaccination
(96.657)
Immunology
(93.948)
Female
(90.914)
Covid-19 Vaccines
(70.899)
Infectious Diseases
(69.272)
Coronaviruses
(69.263)
Male
(64.244)
Covid-19
(60.431)
Biological And Medical Sciences
(55.837)
Microbiology
(52.130)
Infections
(48.961)
Mice
(46.374)
Adult
(43.862)
Pandemics
(43.633)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(209.345)
IngentaConnect Journals
(180.619)
Nexis Uni
(119.266)
Journals@Ovid
(110.062)
IngentaConnect Journals
(95.808)
Single Journals
(90.197)
Factiva
(83.623)
Elsevier ScienceDirect Journals Complete
(79.176)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(65.624)
Wiley Online Library
(51.982)
SpringerNature Journals
(38.970)
JSTOR All Journals
(26.988)
Wiley Online Library
(20.232)
EBSCOhost Business Source Ultimate
(20.211)
Oxford Journals Online Current
(15.902)
Taylor & Francis Current Content Access
(15.416)
Taylor & Francis Journals Complete
(15.209)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(15.160)
Oxford Journals 2020 Medicine
(13.276)
Nature Journals
(12.704)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccine
(28.210)
Cheminform
(19.222)
Pr Newswire
(10.812)
Plos One
(9.086)
M2 Presswire
(7.098)
Business Wire
(6.741)
Vaccines
(6.569)
Human Vaccines & Immunotherapeutics
(5.254)
Reactions Weekly
(5.113)
The Lancet
(4.913)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Vaccine protection against Zika virus from Brazil

Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib)

Recent advancements in combination subunit vaccine development

Advances in gene-based vaccine platforms to address the COVID-19 pandemic

Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

Immunogenicity and Safety of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T, bOPV, and IPV Vaccines Administered at 2, 4, 6 Months of Age Concomitantly With Rotavirus and Pneumococcal Conjugate Vaccines in Healthy Infants in Thailand

Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge

COVID-19 Vaccine: A comprehensive status report

Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine

Recent progress in mucosal vaccine development: potential and limitations

Foot-and-mouth disease vaccines: progress and problems

Immunological considerations for COVID-19 vaccine strategies

SARS-CoV-2 vaccines for cancer patients: a call to action

Causal relationship between immunological responses and adverse reactions following vaccination

Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine

Blick in internationale Zeitschriften

Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study

Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study

An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix ™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children

Virus-like particle-based human vaccines: quality assessment based on structural and functional properties

Plans to expand African vaccine production face steep hurdles

A Review of the Progress and Challenges of Developing a Vaccine for COVID-19

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Turning vaccine design on its head

Suchergebnisse filtern